Abstract
Maternal smoking has been linked to adverse health outcomes in newborns but the extent to which it impacts newborn health has not been quantified through an aggregated cord blood DNA methylation (DNAm) score. Here we propose the first cord blood DNAm score to capture the epigenetic signature of maternal smoking. We first examined the association between individual CpGs and cigarette smoking during pregnancy in two White European birth cohorts (n = 763), and smoking exposure in the White European and the South Asian birth cohorts (n = 887). Several previously reported genes for maternal smoking were supported, with the strongest and most consistent signal from the GFI1 gene (ps < 5×10-5). Leveraging previously reported CpGs for maternal smoking, we constructed a cord blood epigenetic score of maternal smoking that was internally validated in one of the European-origin cohorts. This score was then tested for association with smoking status, secondary smoking exposure during pregnancy, and health outcomes in offspring measured after birth. The epigenetic maternal smoking score was strongly associated with smoking status during pregnancy (p=1.04×10-23) and self-reported smoking exposure (p=6.56×10-8) in White Europeans, but not with self-reported exposure (p > 0.05) in South Asians. The same score was consistently associated with smaller birth size (p =1.19×10-6) and lower birth weight (p =8.79×10-7) in the combined South Asian and White European cohorts. This cord blood epigenetic score can help identify babies exposed to maternal smoking and assess its long-term impact on growth. Notably, even minimal smoking exposure in South Asian mothers who were not active smokers showed a DNAm signature of small body size and low birthweight in newborns.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Canadian Institutes of Health Research Metabolomics Team Grant: MWG-146332.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval: McMaster University. Ethical approval was obtained independently for all studies from the Hamilton Integrated Research Ethics Board CHILD (REB 07-2929), FAMILY (REB 02-060), START (REB 10-640).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The formatting was updated to be identical to the submission to eLife. There is no material change in the content of the manuscript.
Data Availability
The summary statistics used to construct methylation risk scores are available from EWAS catalog at http://www.ewascatalog.org/?trait=maternal%20smoking%20in%20pregnancy with additional filters of PubMID 27040690 and analysis on "Sustained maternal smoking in pregnancy effect on newborns adjusted for cell composition". Summary statistics generated in the current study, including a total of 8 primary association studies (three smoking phenotypes in three cohorts) and 3 sets of meta-analyzed results in Europeans will be made available via zendo. All scripts to reproduce and validate the predictive model can be found at https://github.com/WeiAkaneDeng/EpigeneticResearch/tree/main/MaternalSmoking.
https://github.com/WeiAkaneDeng/EpigeneticResearch/tree/main/MaternalSmoking
